155 related articles for article (PubMed ID: 9625475)
1. The influence of maternal immunity on the development of the in vitro lymphocyte proliferation response against pseudorabies virus in pigs.
Bouma A; De Jong MD; Kimman TG
Res Vet Sci; 1998; 64(2):167-71. PubMed ID: 9625475
[TBL] [Abstract][Full Text] [Related]
2. The influence of maternal immunity on the transmission of pseudorabies virus and on the effectiveness of vaccination.
Bouma A; De Jong MC; Kimman TG
Vaccine; 1997 Feb; 15(3):287-94. PubMed ID: 9139488
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with recombinant vaccinia virus vaccines expressing glycoprotein genes of pseudorabies virus in the presence of maternal immunity.
Brockmeier SL; Lager KM; Mengeling WL
Vet Microbiol; 1997 Nov; 58(2-4):93-103. PubMed ID: 9453121
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs.
van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659
[TBL] [Abstract][Full Text] [Related]
5. Time course of the porcine cellular and humoral immune responses in vivo against pseudorabies virus after inoculation and challenge: significance of in vitro antigenic restimulation.
De Bruin MG; De Visser YE; Kimman TG; Bianchi AT
Vet Immunol Immunopathol; 1998 Sep; 65(1):75-87. PubMed ID: 9802578
[TBL] [Abstract][Full Text] [Related]
6. Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E.
Firkins LD; Weigel RM; Biehl LG; Hahn EC
Am J Vet Res; 1997 Sep; 58(9):976-84. PubMed ID: 9285001
[TBL] [Abstract][Full Text] [Related]
7. Immunohistological characterization of the local cellular response directed against pseudorabies virus in pigs.
Bouma A; Zwart RJ; De Bruin MG; De Jong MC; Kimman TG; Bianchi AT
Vet Microbiol; 1997 Nov; 58(2-4):145-54. PubMed ID: 9453126
[TBL] [Abstract][Full Text] [Related]
8. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs.
Arellano PE; Morrison RB; Molitor TW; Thawley DG
J Am Vet Med Assoc; 1992 Mar; 200(5):685-91. PubMed ID: 1314793
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-12 enhances the virus-specific interferon gamma response of pigs to an inactivated pseudorabies virus vaccine.
Zuckermann FA; Husmann RJ; Schwartz R; Brandt J; Mateu de Antonio E; Martin S
Vet Immunol Immunopathol; 1998 May; 63(1-2):57-67. PubMed ID: 9656441
[TBL] [Abstract][Full Text] [Related]
10. Antibody titers to pseudorabies virus in piglets immunized with gIII deleted pseudorabies vaccine in a pseudorabies infected herd.
Elvinger F; Reeves DE; Pursell AR; Cole JR; Liauw H
Vet Microbiol; 1994 Dec; 42(4):341-8. PubMed ID: 9133059
[TBL] [Abstract][Full Text] [Related]
11. Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs.
van Rooij EM; Haagmans BL; de Visser YE; de Bruin MG; Boersma W; Bianchi AT
Vet Immunol Immunopathol; 1998 Nov; 66(2):113-26. PubMed ID: 9860185
[TBL] [Abstract][Full Text] [Related]
12. Ceftiofur hydrochloride affects the humoral and cellular immune response in pigs after vaccination against swine influenza and pseudorabies.
Pomorska-Mól M; Czyżewska-Dors E; Kwit K; Wierzchosławski K; Pejsak Z
BMC Vet Res; 2015 Oct; 11():268. PubMed ID: 26493336
[TBL] [Abstract][Full Text] [Related]
13. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine.
Zuckermann FA; Martin S; Husmann RJ; Brandt J
Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035
[TBL] [Abstract][Full Text] [Related]
14. Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge.
Vilnis A; Sussman MD; Thacker BJ; Senn M; Maes RK
Vet Microbiol; 1998 May; 62(2):81-96. PubMed ID: 9695282
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a killed gpX deleted pseudorabies virus vaccine.
Cook DR; Hill HT; Kinker DR
Can J Vet Res; 1990 Oct; 54(4):438-45. PubMed ID: 2174294
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs.
Mengeling WL; Brockmeier SL; Lager KM
Arch Virol; 1994; 134(3-4):259-69. PubMed ID: 8129615
[TBL] [Abstract][Full Text] [Related]
17. Immune response of pigs inoculated with virulent pseudorabies virus and pigs inoculated with attenuated or inactivated pseudorabies virus vaccine before and after challenge exposure.
Kelling CL; Staudinger WL; Rhodes MB
Am J Vet Res; 1982 Dec; 43(12):2114-20. PubMed ID: 6299139
[TBL] [Abstract][Full Text] [Related]
18. A DNA vaccine coding for gB and gD of pseudorabies virus (suid herpes type 1) primes the immune system in the presence of maternal immunity more efficiently than conventional vaccines.
van Rooij EM; Moonen-Leusen HW; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
Vaccine; 2006 Feb; 24(9):1264-73. PubMed ID: 16289276
[TBL] [Abstract][Full Text] [Related]
19. Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs.
Wang Y; Yuan J; Cong X; Qin HY; Wang CH; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
Clin Vaccine Immunol; 2015 Oct; 22(10):1121-9. PubMed ID: 26311244
[TBL] [Abstract][Full Text] [Related]
20. A study of the ability of a TK-negative and gI/gE-negative pseudorabies virus (PRV) mutant inoculated by different routes to protect pigs against PRV infection.
Ferrari M; Brack A; Romanelli MG; Mettenleiter TC; Corradi A; Dal Mas N; Losio MN; Silini R; Pinoni C; Pratelli A
J Vet Med B Infect Dis Vet Public Health; 2000 Dec; 47(10):753-62. PubMed ID: 11204130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
